1dsm: Difference between revisions

No edit summary
No edit summary
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1dsm.gif|left|200px]]


<!--
==(-)-duocarmycin SA covalently linked to duplex DNA==
The line below this paragraph, containing "STRUCTURE_1dsm", creates the "Structure Box" on the page.
<StructureSection load='1dsm' size='340' side='right'caption='[[1dsm]]' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[1dsm]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DSM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1DSM FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
-->
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DSA:4-HYDROXY-8-METHYL-6-(4,5,6-TRIMETHOXY-1H-INDOLE-2-CARBONYL)-3,6,7,8-TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2-CARBOXYLIC+ACID+METHYL+ESTER'>DSA</scene></td></tr>
{{STRUCTURE_1dsm| PDB=1dsm  |  SCENE= }}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1dsm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1dsm OCA], [https://pdbe.org/1dsm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1dsm RCSB], [https://www.ebi.ac.uk/pdbsum/1dsm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1dsm ProSAT]</span></td></tr>
 
</table>
'''(-)-duocarmycin SA covalently linked to duplex DNA'''
<div style="background-color:#fffaf0;">
 
== Publication Abstract from PubMed ==
 
==Overview==
Duocarmycin SA is a member of a growing class of interesting lead compounds for chemotherapy, distinguished by the manner in which they bind to and react with DNA substrates. The first three-dimensional structure of a DNA adduct of an unnatural enantiomer from this family has been determined by (1)H NMR methods. Comparison to the previously determined structure of the natural enantiomer bound in the same DNA-binding site provides unique insights into the similarities and critical distinctions producing the respective alkylation products and site selectivities. The results also support the hypothesis that the duocarmycin SA alkylation reaction is catalyzed by the binding to DNA, and provide a deeper understanding of the structural basis for this unique mode of activation.
Duocarmycin SA is a member of a growing class of interesting lead compounds for chemotherapy, distinguished by the manner in which they bind to and react with DNA substrates. The first three-dimensional structure of a DNA adduct of an unnatural enantiomer from this family has been determined by (1)H NMR methods. Comparison to the previously determined structure of the natural enantiomer bound in the same DNA-binding site provides unique insights into the similarities and critical distinctions producing the respective alkylation products and site selectivities. The results also support the hypothesis that the duocarmycin SA alkylation reaction is catalyzed by the binding to DNA, and provide a deeper understanding of the structural basis for this unique mode of activation.


==About this Structure==
The structural basis for in situ activation of DNA alkylation by duocarmycin SA.,Smith JA, Bifulco G, Case DA, Boger DL, Gomez-Paloma L, Chazin WJ J Mol Biol. 2000 Jul 28;300(5):1195-204. PMID:10903864<ref>PMID:10903864</ref>
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DSM OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
The structural basis for in situ activation of DNA alkylation by duocarmycin SA., Smith JA, Bifulco G, Case DA, Boger DL, Gomez-Paloma L, Chazin WJ, J Mol Biol. 2000 Jul 28;300(5):1195-204. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10903864 10903864]
</div>
[[Category: Case, D A.]]
<div class="pdbe-citations 1dsm" style="background-color:#fffaf0;"></div>
[[Category: Chazin, W J.]]
== References ==
[[Category: Smith, J A.]]
<references/>
[[Category: Antitumor agent]]
__TOC__
[[Category: Dna]]
</StructureSection>
[[Category: Drug-dna complex]]
[[Category: Large Structures]]
[[Category: Duocarmycin]]
[[Category: Case DA]]
[[Category: Minor groove binding]]
[[Category: Chazin WJ]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 14:13:32 2008''
[[Category: Smith JA]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA